Evidence map›Paper›PMID 39008676›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Conformational dynamics underlying atypical chemokine receptor 3 activation.

Omolade Otun, Christelle Aljamous, Elise Del Nero, Marta Arimont-Segura, Reggie Bosma, Barbara Zarzycka, Tristan Girbau, Cédric Leyrat, Chris de Graaf, Rob Leurs and 4 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. State-of-the-Art and Future Directions in Structural Proteomics.Molecular & cellular proteomics : MCP · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Omolade OtunInstitut de Génomique Fonctionnelle, University of Montpellier, CNRS, INSERM, Montpellier Cedex 5 34094, France.
Christelle AljamousInstitut de Génomique Fonctionnelle, University of Montpellier, CNRS, INSERM, Montpellier Cedex 5 34094, France.
Elise Del NeroInstitut de Génomique Fonctionnelle, University of Montpellier, CNRS, INSERM, Montpellier Cedex 5 34094, France.
Marta Arimont-SeguraDepartment of Medicinal Chemistry, Amsterdam Institute for Molecular Life Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam 1081 HV, The Netherlands.
Reggie BosmaDepartment of Medicinal Chemistry, Amsterdam Institute for Molecular Life Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam 1081 HV, The Netherlands.
Barbara ZarzyckaDepartment of Medicinal Chemistry, Amsterdam Institute for Molecular Life Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam 1081 HV, The Netherlands.
Tristan GirbauInstitut de Génomique Fonctionnelle, University of Montpellier, CNRS, INSERM, Montpellier Cedex 5 34094, France.ORCID 0009-0006-2402-4703
Cédric LeyratInstitut de Génomique Fonctionnelle, University of Montpellier, CNRS, INSERM, Montpellier Cedex 5 34094, France.
Chris de GraafDepartment of Medicinal Chemistry, Amsterdam Institute for Molecular Life Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam 1081 HV, The Netherlands.ORCID 0000-0002-1226-2150
Rob LeursDepartment of Medicinal Chemistry, Amsterdam Institute for Molecular Life Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam 1081 HV, The Netherlands.
Thierry DurrouxInstitut de Génomique Fonctionnelle, University of Montpellier, CNRS, INSERM, Montpellier Cedex 5 34094, France.ORCID 0000-0003-1091-6066
Sébastien GranierInstitut de Génomique Fonctionnelle, University of Montpellier, CNRS, INSERM, Montpellier Cedex 5 34094, France.ORCID 0000-0003-1550-3658
Xiaojing CongInstitut de Génomique Fonctionnelle, University of Montpellier, CNRS, INSERM, Montpellier Cedex 5 34094, France.
Cherine BecharaInstitut de Génomique Fonctionnelle, University of Montpellier, CNRS, INSERM, Montpellier Cedex 5 34094, France.ORCID 0000-0002-5539-6327

Funding

Agence Nationale de la Recherche (ANR) ANR-21-CE44-0007Agence Nationale de la Recherche (ANR) R19168LLEC | H2020 | PRIORITY 'Excellent science' | H2020 Marie Skłodowska-Curie Actions (MSCA) 641833EC | H2020 | PRIORITY 'Excellent science' | H2020 Marie Skłodowska-Curie Actions (MSCA) 860229
6 · The paper itself

Abstract

Atypical Chemokine Receptor 3 (ACKR3) belongs to the G protein-coupled receptor family but it does not signal through G proteins. The structural properties that govern the functional selectivity and the conformational dynamics of ACKR3 activation are poorly understood. Here, we combined hydrogen/deuterium exchange mass spectrometry, site-directed mutagenesis, and molecular dynamics simulations to examine the binding mode and mechanism of action of ACKR3 ligands of different efficacies. Our results show that activation or inhibition of ACKR3 is governed by intracellular conformational changes of helix 6, intracellular loop 2, and helix 7, while the DRY motif becomes protected during both processes. Moreover, we identified the binding sites and the allosteric modulation of ACKR3 upon β-arrestin 1 binding. In summary, this study highlights the structure-function relationship of small ligands, the binding mode of β-arrestin 1, the activation dynamics, and the atypical dynamic features in ACKR3 that may contribute to its inability to activate G proteins.

Indexed as

Molecular Dynamics SimulationProtein BindingReceptors, CXCRAllosteric Regulationbeta-Arrestin 1Binding SitesHEK293 CellsHumansLigandsMutagenesis, Site-DirectedProtein ConformationStructure-Activity RelationshipACKR3 protein, humanbeta-Arrestin 1LigandsReceptors, CXCRACKR3GPCR conformational dynamicsHDX-MSMD simulations

Identifiers

PMID39008676
PMCPMC11287255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.